1. 2022
  2. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

    Antic, D., Milic, N., Chatzikonstantinou, T., Scarfò, L., Otasevic, V., Rajovic, N., Allsup, D., Alonso Cabrero, A., Andres, M., Baile Gonzales, M., Capasso, A., Collado, R., Cordoba, R., Cuéllar-García, C., Correa, J. G., de Paoli, L., de Paolis, M. R., del Poeta, G., Dimou, M., Doubek, M. & 81 others, Efstathopoulou, M., el-Ashwah, S., Enrico, A., Espinet, B., Farina, L., Ferrari, A., Foglietta, M., Lopez-Garcia, A., García-Marco, J. A., García-Serra, R., Gentile, M., Gimeno, E., da Silva, M. G., Gutwein, O., Hakobyan, Y. K., Herishanu, Y., Hernández-Rivas, J. Á., Herold, T., Itchaki, G., Jaksic, O., Janssens, A., Kalashnikova, O. B., Kalicińska, E., Kater, A. P., Kersting, S., Koren-Michowitz, M., Labrador, J., Lad, D., Laurenti, L., Fresa, A., Levin, M-D., Mayor Bastida, C., Malerba, L., Marasca, R., Marchetti, M., Marquet, J., Mihaljevic, B., Milosevic, I., Mirás, F., Morawska, M., Motta, M., Munir, T., Murru, R., Nunes, R., Olivieri, J., Pavlovsky, M. A., Piskunova, I., Popov, V. M., Quaglia, F. M., Quaresmini, G., Reda, G., Rigolin, G. M., Shrestha, A., Šimkovič, M., Smirnova, S., Špaček, M., Sportoletti, P., Stanca, O., Stavroyianni, N., te Raa, D., Tomic, K., Tonino, S., Trentin, L., van der Spek, E., van Gelder, M., Varettoni, M., Visentin, A., Vitale, C., Vukovic, V., Wasik-Szczepanek, E., Wróbel, T., Segundo, L. Y. Ñ. S., Yassin, M., Coscia, M., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A., Carrier, M., Ghia, P. & Stamatopoulos, K., Dec 2022, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 15, 1, p. 116 116.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma

    Thus, Y. J., Eldering, E., Kater, A. P. & Spaargaren, M., Sep 2022, In: Leukemia. 36, 9, p. 2165-2176 12 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

    Seymour, J. F., Kipps, T. J., Eichhorst, B. F., D'Rozario, J., Owen, C. J., Assouline, S., Lamanna, N., Robak, T., de la Serna, J., Jaeger, U., Cartron, G., Montillo, M., Mellink, C., Chyla, B., Panchal, A., Lu, T., Wu, J. Q., Jiang, Y., Lefebure, M., Boyer, M. & 1 others, Kater, A. P., 25 Aug 2022, In: Blood. 140, 8, p. 839-850 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment

    Chen, Z., Simon-Molas, H., Cretenet, G., Valle-Argos, B., Smith, L. D., Forconi, F., Schomakers, B. V., van Weeghel, M., Bryant, D. J., van Bruggen, J. A. C., Peters, F. S., Rathmell, J. C., van der Windt, G. J. W., Kater, A. P., Packham, G. & Eldering, E., 11 Aug 2022, In: Blood. 140, 6, p. 630-643 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

    Thompson, M. C., Harrup, R. A., Coombs, C. C., Roeker, L. E., Pu, J. J., Choi, M. Y., Barr, P. M., Allan, J. N., Simkovi, M., Leslie, L., Rhodes, J., Chong, E. A., Kamdar, M., Skarbnik, A., Lansigan, F., McCall, B., Saja, K., Dyer, M. J. S., Walter, H. S., Lefebure, M. & 18 others, Thadani-Mulero, M., Boyer, M., Biondo, J., Sail, K., Manzoor, B. S., Furman, R., Bantilan, K. S., Goy, A., Feldman, T., Labella, D., Schuster, S. J., Park, J., Palomba, L., Zelenetz, A., Eyre, T. A., Kater, A. P., Seymour, J. F. & Mato, A. R., 9 Aug 2022, In: Blood advances. 6, 15, p. 4553-4557 5 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  7. Obinutuzumab in the treatment of B-cell malignancies: a comprehensive review

    Davies, A., Kater, A. P., Sharman, J. P., Stilgenbauer, S., Vitolo, U., Klein, C., Parreira, J. & Salles, G., 1 Aug 2022, In: Future oncology (London, England). 18, 26, p. 2943-2966 24 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  8. Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells

    van Bruggen, J. A. C., van der Windt, G. J. W., Hoogendoorn, M., Dubois, J., Kater, A. P. & Peters, F. S., 26 Jul 2022, In: Blood advances. 6, 14, p. 4185-4195 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110

    Hengeveld, P. J., Ertem, Y. E., Dubois, J. M. N., Mellink, C. H. M., van der Kevie-Kersemaekers, A-M., Evers, L. M., Heezen, K., Kolijn, P. M., Mook, O. R. F., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P. E., Niemann, C. U., Kater, A. P., Langerak, A. W. & Levin, M-D., Jul 2022, In: Leukemia. 36, 7, p. 1935-1938 4 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A-M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T. & 2 others, Nasserinejad, K. & Niemann, C. U., 1 Jun 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

    Baliakas, P., Espinet, B., Mellink, C., Jarosova, M., Athanasiadou, A., Ghia, P., Kater, A. P., Oscier, D., Haferlach, C. & Stamatopoulos, K., 25 Apr 2022, In: HemaSphere. 6, 4, p. E707

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 64520